CellWell record HH-352738
Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis.
Ahmed A. Abo Elnaga; M. Alsaied; A. Elettreby; Alaa Ramadan
European Journal of Obstetrics, Gynecology, and Reproductive Biology ยท 2024
In plain language
Meta-analysis showed fezolinetant reduces vasomotor symptom frequency and severity with improved quality of life, though with increased risk of fatigue and elevated liver enzymes.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-352738
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.